NCT06809023

Brief Summary

The goal of this study is to learn whether insufficient sleep affects glucose metabolism differently in healthy men and women.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
34mo left

Started Apr 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
Apr 2026Feb 2029

First Submitted

Initial submission to the registry

January 24, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 5, 2025

Completed
1.2 years until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2029

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2029

Last Updated

December 10, 2025

Status Verified

December 1, 2025

Enrollment Period

2.8 years

First QC Date

January 24, 2025

Last Update Submit

December 9, 2025

Conditions

Keywords

glucose metabolismsleep deprivationsex differencesGLP-1

Outcome Measures

Primary Outcomes (2)

  • Difference between men and women in postprandial glucose response after Sleep Restriction

    Test the hypothesis that three nights of sleep curtailment increases postprandial glucose levels to a greater extent in women compared to men. Postprandial glucose will be assessed in response to a standard meal after Control and Sleep Restriction. The change in postprandial glucose from Control to Sleep Restriction will be compared between men and women.

    Study Day 4 (Arm 1) vs. Study Day 4 (Arm 2)

  • Difference between men and women in postprandial GLP-1 response after Sleep Restriction

    Test the hypothesis that three nights of sleep curtailment decreases postprandial GLP-1 levels to a greater extent in women compared to men. Postprandial GLP-1 levels will be assessed in response to a standard meal after Control and Sleep Restriction. The change in postprandial GLP-1 from Control to Sleep Restriction will be compared between men and women.

    Study Day 4 (Arm 1) vs. Study Day 4 (Arm 2)

Secondary Outcomes (2)

  • Difference between men and women in fasting glucose after Sleep Restriction

    Study Day 5 (Arm 1) vs. Study Day 5 (Arm 2)

  • Difference between men and women in fasting GLP-1 after Sleep Restriction

    Study Day 5 (Arm 1) vs. Study Day 5 (Arm 2)

Study Arms (2)

Sleep restriction

EXPERIMENTAL

Participants undergo sleep restriction to 4 hours/night

Behavioral: Sleep restriction

Control condition

NO INTERVENTION

Participants undergo the control condition (no sleep restriction)

Interventions

Participants will be asked to sleep 4h/night

Sleep restriction

Eligibility Criteria

Age20 Years - 40 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsAt this time, we are recruiting cisgender men and women
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy adults with conventional sleep-wake timing
  • Non-smokers
  • Completion of medical, psychological, and sleep screening tests
  • Able to spend 5 consecutive days/nights in the laboratory on two separate occasions (total of 10 days/nights in the laboratory)
  • Women must have a recent history of regular menstrual cycles

You may not qualify if:

  • History of neurological or psychiatric disorder
  • History of sleep disorder or regular use of sleep-promoting medication
  • Current prescription, herbal, or over-the-counter medication use including hormonal birth control
  • Traveling across 2 or more time zones within past 3 months
  • Donating blood within past 8 weeks
  • Worked night or rotating shift work within past year
  • Hearing impairment, visual impairment
  • History of eye trauma or surgery
  • Drug or alcohol dependency

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

MeSH Terms

Conditions

Sleep Deprivation

Condition Hierarchy (Ancestors)

DyssomniasSleep Wake DisordersNervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The order in which participants complete the study arms is randomized
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: This study uses a within-subjects randomized crossover design to compare the effects of sleep restriction to a control condition where participants are not sleep restricted.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Sleep Medicine

Study Record Dates

First Submitted

January 24, 2025

First Posted

February 5, 2025

Study Start

April 1, 2026

Primary Completion (Estimated)

January 1, 2029

Study Completion (Estimated)

February 1, 2029

Last Updated

December 10, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations